Perspectives About Ascorbic Acid to Treat Inflammatory Bowel Diseases

Abstract

It is known that reactive oxygen species cause abnormal immune responses in the gut during inflammatory bowel diseases (IBD). Therefore, oxidative stress has been theorized as an agent of IBD development and antioxidant compounds such as vitamin C (L-ascorbic acid) have been studied as a new tool to treat IBD. Therefore, the potential of vitamin C to treat IBD was reviewed here as a critical discussion about this field and guide future research. Indeed, some preclinical studies have shown the beneficial effects of vitamin C in models of ulcerative colitis in mice and clinical and experimental findings have shown that deficiency in this vitamin is associated with the development of IBD and its worsening. The main mechanisms that may be involved in the activity of ascorbic acid in IBD include its well-established role as an antioxidant, but also others diversified actions. However, some experimental studies employed high doses of vitamin C and most of them did not perform dose-response curves and neither determined the minimum effective dose nor the ED₅₀. Allometric extrapolations were also not made. Also, clinical studies on the subject are still in their infancy. Therefore, it is suggested that the research agenda in this matter covers experimental studies that assess the effective, safe, and translational doses, as well as the appropriate administration route and its action mechanism. After that, robust clinical trials to increase knowledge about the role of ascorbic acid deficiency in IBD patients and the effects of their supplementation in these patients can be encouraged.

Keywords

ascorbic acid - colitis - inflammation - oxidative stress - reactive oxygen species - vitamin

^‡ The authors had an equal contribution: Ian Richard Lucena Andriolo, Larissa Venzon

Publication History

Received: 28 December 2023

Accepted: 05 February 2024

Article published online:
11 March 2024

• References

• 1 Cai Z, Wang S, Li J. Treatment of Inflammatory Bowel Disease: A Comprehensive Review. Front Med (Lausanne) 2021; 8: 7654-7674
• 2 Faye AS, Colombel JF. Aging and IBD: A New Challenge for Clinicians and Researchers. Inflamm Bowel Dis 2022; 28: 126-132
• 3 Saez A, Herrero-Fernandez B, Gomez-Bris R, Sánchez-Martinez H, Gonzalez-Granado JM. Pathophysiology of Inflammatory Bowel Disease: Innate Immune System. Int J Mol Sci 2023; 24: 1526
• 4 Windsor JW, Kaplan GG. Evolving Epidemiology of IBD. Curr Gastroenterol Rep 2019; 21: 40 PMID: 31338613
• 5 Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol 2015; 12: 205-217
• 6 Kaplan GG, Windsor JW. The four epidemiological stages in the global evolution of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 2021; 18: 56-66
• 7 Cai Z, Wang S, Li J. Treatment of Inflammatory Bowel Disease: A Comprehensive Review. Front Med (Lausanne) 2021; 8: 765474
• 8 Meurer MC, Mees M, Mariano LNB, Boieng T, Somensi LB, Mariott M, Silva RCMVAF, Santos ACD, Longo B, França TCS, Klein-Junior LC, Souza P, Andrade SF, Silva LM. Hydroalcoholic extract of Tagetes erecta L. flowers, rich in the carotenoid lutein, attenuates inflammatory cytokine secretion and improves the oxidative stress in an animal model of ulcerative colitis. Nutr Res 2019; 66: 95-106
• 9 Poljsak B, Milisav I. The Role of Antioxidants in Cancer, Friends or Foes?. Curr Pharm Des 2018; 24: 5234-5244
• 10 Georgiopoulos G, Chrysohoou C, Vogiatzi G, Magkas N, Bournelis I, Bampali S, Gruson D, Tousoulis D. Vitamins in Heart Failure: Friend or Enemy?. Curr Pharm Des 2017; 23: 3731-3742
• 11 Da Silva LM, Da Silva RCMVAF, Maria-Ferreira D, Beltrame OC, da Silva-Santos JE, Werner MFP. Vitamin C Improves Gastroparesis in Diabetic Rats: Effects on Gastric Contractile Responses and Oxidative Stress. Dig Dis Sci 2017; 62: 2338-2347
• 12 Caritá AC, Fonseca-Santos B, Shultz JD, Michniak-Kohn B, Chorilli M, Leonardi GR. Vitamin C: One compound, several uses. Advances for delivery, efficiency and stability. Nanomedicine. 2020; 24: 102117
• 13 Buffinton GD, Doe WF. Altered ascorbic acid status in the mucosa from inflammatory bowel disease patients. Free Rad Res 1995; 22: 131-143
• 14 Kawade N, Murai A, Suzuki W, Takeuchi K, Kondo M, Kobayashi M, Horio F. Ascorbic acid deficiency induces hepatic and intestinal expression of inflammation-related genes irrespective of the presence or absence of gut microbiota in ODS rats. J Nutr Biochem 2020; 86: 1084-1085
• 15 Kawade N, Murai A, Suzuki W, Tokuda Y, Kobayashi M, Horio F. Ascorbic acid deficiency increases hepatic expression of acute phase proteins through the intestine-derived IL-6 and hepatic STAT3 pathway in ODS rats. J Nutr Biochem 2019; 70: 116-124
• 16 Kawade N, Suzuki W, Kobayashi M, Ohno T, Murai A, Horio F. Low Ascorbic Acid Intake Induces Inflammatory Changes in Intestine and Liver of ODS Rats. J Nutr Sci Vitaminol 2022; 68: 481-487
• 17 Subramanian VS, Sabui S, Moradi H, Marchant JS, Said HM. Inhibition of intestinal ascorbic acid uptake by lipopolysaccharide is mediated via transcriptional mechanisms. Biochim Biophys Acta 2018; 1860: 556-565
• 18 Vitale S, Strisciuglio C, Pisapia L, Miele E, Barba P, Vitale A, Cenni S, Bassi V, Maglio M, Del Pozzo G, Troncone R, Staiano A, Gianfrani C. Cytokine production profile in intestinal mucosa of paediatric inflammatory bowel disease. 2017. PLoS One 2017; 12: 182-313
• 19 Subramanian VS, Sabui S, Subramenium GA, Marchant JS, Said HM. Tumor necrosis factor alpha reduces intestinal vitamin C uptake: a role for NF-κB-mediated signaling. Am J Physiol Gastrointest Liver Physiol 2018; 315: 241-48
• 20 Dunleavy KA, Ungaro RC, Manning L, Gold S, Novak J, Colombel JF. Vitamin C Deficiency in Inflammatory Bowel Disease: The Forgotten Micronutrient. Crohns Colitis 360 2021; 3: 009
• 21 Gordon BL, Galati JS, Yang S, Longman RS, Lukin D, Scherl EJ, Battat R. Prevalence and factors associated with vitamin C deficiency in inflammatory bowel disease. World J Gastroenterol 2022; 28: 4834-4845
• 22 Yan H, Wang H, Zhang X, Li X, Yu J. Ascorbic acid ameliorates oxidative stress and inflammation in dextran sulfate sodium-induced ulcerative colitis in mice. Int J Clin Exp Med 2015; 8: 20245-20253
• 23 Jeon HJ, Yeom Y, Kim YS, Kim E, Shin JH, Seok PR, Woo MJ, Kim Y. Effect of vitamin C on azoxymethane (AOM)/dextran sulfate sodium (DSS)-induced colitis-associated early colon cancer in mice. Nutr Res Pract 2018; 12: 101-109
• 24 Kondo K, Hiramoto K, Yamate Y, Goto K, Sekijima H, Ooi K. Ameliorative Effect of High-Dose Vitamin C Administration on Dextran Sulfate Sodium-Induced Colitis Mouse Model. Biol Pharm Bull 2019; 42: 954-959
• 25 Huang K, Yan Y, Chen D, Zhao Y, Dong W, Zeng X, Cao Y. Ascorbic Acid Derivative 2-O-β-d-Glucopyranosyl-l-Ascorbic Acid from the Fruit of Lycium barbarum Modulates Microbiota in the Small Intestine and Colon and Exerts an Immunomodulatory Effect on Cyclophosphamide-Treated BALB/c Mice. J Agric Food Chem 2020; 68: 11128-11143
• 26 Honjo T, Toyota K, Kanada M, Itoh T. Vitamin C Enema Advances Induction of Remission in the Dextran Sodium Sulfate-Induced Colitis Model in Rats. J Nutr Sci Vitaminol (Tokyo) 2021; 67: 91-98
• 27 Qi Y, Lohman J, Bratlie KM, Peroutka-Bigus N, Bellaire B, Wannemuehler M, Yoon KJ, Barrett TA, Wang Q. Vitamin C and B3 as new biomaterials to alter intestinal stem cells. J Biomed Mater Res A. 2019; 107: 1886-1897
• 28 Qiu F, Zhang Z, Yang L, Li R, Ma Y. Combined effect of vitamin C and vitamin D3 on intestinal epithelial barrier by regulating Notch signaling pathway. Nutr Metab (Lond) 2021; 18: 49
• 29 Jo H, Lee D, Go C, Jang Y, Chu N, Bae S, Kang D, Im JP, Kim Y, Kang JS. Preventive Effect of Vitamin C on Dextran Sulfate Sodium (DSS)-Induced Colitis via the Regulation of IL-22 and IL-6 Production in Gulo(-/-) Mice. Int J Mol Sci 2022; 23: 106-12
• 30 Gęgotek A, Skrzydlewska E. Antioxidative and Anti-Inflammatory Activity of Ascorbic Acid. Antioxidants (Basel) 2022; 11: 1993
• 31 Doseděl M, Jirkovský E, Macáková K, Kujovská Krčmová L, Javorská L, Pourová J, Mercolini L, Remião F, Nováková L, Mladěnka P. Vitamin C-Sources, Physiological Role, Kinetics, Deficiency, Use, Toxicity, and Determination. Nutrients. 2021; 13: 615
• 32 Kaźmierczak-Barańska J, Boguszewska K, Adamus-Grabicka A, Karwowski BT. Two Faces of Vitamin C-Antioxidative and Pro-Oxidative Agent. Nutrients. 2020; 12: 1501
• 33 Chambial S, Dwivedi S, Shukla KK, John PJ, Sharma P. Vitamin C in disease prevention and cure: An overview. Indian J Clin Biochem 2013; 28: 314-28
• 34 Chiarugi A, Dölle C, Felici R, Ziegler M. The NAD metabolome--a key determinant of cancer cell biology. Nat Rev Cancer 2012; 12: 741-52
• 35 Huxley L, Quirk PG, Cotton NPJ, White SA, Jackson JB. The specificity of proton-translocating transhydrogenase for nicotinamide nucleotides. Biochim Biophys Acta 2011; 1807: 85-94